(Q38667035)

5 September 2017

Role of the TWEAK/Fn14 pathway in autoimmune diseases (English)

1 reference

5 September 2017

Wang-Dong Xu

1

1 reference

5 September 2017

Yi Zhao

series ordinal

2

1 reference

5 September 2017

Yi Liu

series ordinal

3

1 reference

5 September 2017

language of work or name

1 reference

12 December 2015

1 reference

5 September 2017

1 reference

5 September 2017

64

1 reference

5 September 2017

1

1 reference

5 September 2017

44-50

1 reference

https://scigraph.springernature.com/pub.10.1007/s12026-015-8761-y

5 September 2017

0 references

cites work

Signalling pathways of the TNF superfamily: a double-edged sword

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8761-Y

TWEAK/Fn14 pathway: an immunological switch for shaping tissue responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8761-Y

The TWEAK-Fn14 cytokine-receptor axis: discovery, biology and therapeutic targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8761-Y

TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8761-Y

TWEAK, a member of the TNF superfamily, is a multifunctional cytokine that binds the TweakR/Fn14 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8761-Y

The role of TWEAK/Fn14 in the pathogenesis of inflammation and systemic autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8761-Y

TWEAK attenuates the transition from innate to adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8761-Y

A novel TNF receptor family member binds TWEAK and is implicated in angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8761-Y

TWEAK, a multifunctional cytokine in kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8761-Y

Considering TWEAK as a target for therapy in renal and vascular injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8761-Y

TNF-like weak inducer of apoptosis (TWEAK) activates proinflammatory signaling pathways and gene expression through the activation of TGF-beta-activated kinase 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8761-Y

Fn14 in podocytes and proteinuric kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8761-Y

The cytokine TWEAK modulates renal tubulointerstitial inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8761-Y

TWEAK can induce pro-inflammatory cytokines and matrix metalloproteinase-9 in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8761-Y

Integrating signals from RTKs to ERK/MAPK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8761-Y

Relevant role of PKG in the progression of fibrosis induced by TNF-like weak inducer of apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8761-Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8761-Y

TWEAK transactivation of the epidermal growth factor receptor mediates renal inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8761-Y

Interferon regulatory factor 5 and autoimmune lupus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8761-Y

Elevation of human tumor necrosis factor-like weak inducer of apoptosis in peripheral blood mononuclear cells is correlated with disease activity and lupus nephritis in patients with systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8761-Y

Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8761-Y

Urinary TWEAK level as a marker of lupus nephritis activity in 46 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8761-Y

IL-33 in rheumatoid arthritis: potential role in pathogenesis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8761-Y

TWEAK promotes osteoclastogenesis in rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8761-Y

Relationship of serum TWEAK level to cytokine level, disease activity, and response to anti-TNF treatment in patients with rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8761-Y

TWEAK and Fn14 expression in the pathogenesis of joint inflammation and bone erosion in rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8761-Y

TWEAK and its receptor Fn14 in the synovium of patients with rheumatoid arthritis compared to psoriatic arthritis and its response to tumour necrosis factor blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8761-Y

Safety, tolerability, pharmacokinetics, and pharmacodynamics of anti-TWEAK monoclonal antibody in patients with rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8761-Y

Inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8761-Y

Interleukin-13 damages intestinal mucosa via TWEAK and Fn14 in mice-a pathway associated with ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8761-Y

Deficiency of fibroblast growth factor-inducible 14 (Fn14) preserves the filtration barrier and ameliorates lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8761-Y

TWEAK/Fn14 Signaling Involvement in the Pathogenesis of Cutaneous Disease in the MRL/lpr Model of Spontaneous Lupus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8761-Y

Neuropsychiatric disease in murine lupus is dependent on the TWEAK/Fn14 pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8761-Y

Proinflammatory activity of TWEAK on human dermal fibroblasts and synoviocytes: blocking and enhancing effects of anti-TWEAK monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8761-Y

TWEAK/Fn14 pathway: a nonredundant role in intestinal damage in mice through a TWEAK/intestinal epithelial cell axis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8761-Y

Emerging approaches for the therapy of autoimmune and chronic inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8761-Y

Immune therapies of autoimmune diseases: are we approaching a real cure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-015-8761-Y

Correlations of urinary biomarkers, TNF-like weak inducer of apoptosis (TWEAK), osteoprotegerin (OPG), monocyte chemoattractant protein-1 (MCP-1), and IL-8 with lupus nephritis

21 January 2018

1 reference

12 December 2020

TWEAK/Fn14 pathway promotes a T helper 2-type chronic colitis with fibrosis in mice

1 reference

12 December 2020

Involvement of TNF-like weak inducer of apoptosis in the pathogenesis of collagen-induced arthritis

1 reference

12 December 2020

Expression of human tumor necrosis factor-like weak inducer of apoptosis in patients with systemic lupus erythematosus

1 reference

12 December 2020

The antiinflammatory sesquiterpene lactone parthenolide inhibits NF-kappa B by targeting the I kappa B kinase complex.

1 reference

12 December 2020

Pathological activation of canonical nuclear-factor κB by synergy of tumor necrosis factor α and TNF-like weak inducer of apoptosis in mouse acute colitis

1 reference

12 December 2020

Gene expression of TWEAK/Fn14 and IP-10/CXCR3 in glomerulus and tubulointerstitium of patients with lupus nephritis

1 reference

12 December 2020

Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) mediates p38 mitogen-activated protein kinase activation and signal transduction in peripheral blood mononuclear cells from patients with lupus nephritis

1 reference

12 December 2020

Small GTP-binding proteins

1 reference

12 December 2020

Involvement of TWEAK/Fn14 interaction in the synovial inflammation of RA

1 reference

12 December 2020

TWEAK promotes the production of Interleukin-17 in rheumatoid arthritis

1 reference

12 December 2020

Nuclear factor-kappa B p65 mediates the assembly and activation of the TNF-responsive element of the murine monocyte chemoattractant-1 gene.

1 reference

12 December 2020

Mouse models of inflammatory bowel disease

1 reference

12 December 2020

TWEAK is a novel arthritogenic mediator

1 reference

12 December 2020

10.1007/S12026-015-8761-Y

Identifiers

DOI

1 reference

Dimensions Publication ID

5 September 2017

0 references

1 reference